138 related articles for article (PubMed ID: 11435010)
41. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador.
Díaz J; Chedraui P; Hidalgo L; Medina M
J Matern Fetal Neonatal Med; 2009 Feb; 22(2):89-93. PubMed ID: 19085632
[TBL] [Abstract][Full Text] [Related]
42. Effect of digital cervical examination on the expression of fetal fibronectin.
McKenna DS; Chung K; Iams JD
J Reprod Med; 1999 Sep; 44(9):796-800. PubMed ID: 10509304
[TBL] [Abstract][Full Text] [Related]
43. [Quantitative determination of fetal fibronectin in cervical smears: a new marker for evaluating the risk of premature labor].
Hampl M; Friese K; Hofmann I; Melchert F
Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):685-90. PubMed ID: 7851710
[TBL] [Abstract][Full Text] [Related]
44. Significance of cervical gland area in predicting preterm birth for patients with threatened preterm delivery: comparison with cervical length and fetal fibronectin.
Asakura H; Fukami T; Kurashina R; Tateyama N; Doi D; Takeshita T
Gynecol Obstet Invest; 2009; 68(1):1-8. PubMed ID: 19321961
[TBL] [Abstract][Full Text] [Related]
45. Fetal fibronectin in cervicovaginal secretions as a predictor of preterm birth.
Malak TM; Sizmur F; Bell SC; Taylor DJ
Br J Obstet Gynaecol; 1996 Jul; 103(7):648-53. PubMed ID: 8688390
[TBL] [Abstract][Full Text] [Related]
46. Characterization of the inflammatory cytokines in the vagina during pregnancy and labor and with bacterial vaginosis.
Imseis HM; Greig PC; Livengood CH; Shunior E; Durda P; Erikson M
J Soc Gynecol Investig; 1997; 4(2):90-4. PubMed ID: 9101468
[TBL] [Abstract][Full Text] [Related]
47. [Presence of fetal fibronectin in cervico-vaginal secretion as predictor of premature labor].
García Alonso A; Ayala Méndez JA; Izquierdo Puente JC; Jiménez Solís G; Sánchez Martínez M
Ginecol Obstet Mex; 1999 Jan; 67():23-8. PubMed ID: 10085606
[TBL] [Abstract][Full Text] [Related]
48. Microbiological characteristics and inflammatory cytokines associated with preterm labor.
Discacciati MG; Simoes JA; Silva MG; Marconi C; Brolazo E; Costa ML; Cecatti JG
Arch Gynecol Obstet; 2011 Mar; 283(3):501-8. PubMed ID: 20237933
[TBL] [Abstract][Full Text] [Related]
49. [Clinical usefulness of fetal fibronectin (fFN) expression in cervico-vaginal secretions (CVS)].
García Alonso LA; Jiménez SG; Ayala Méndez JA; Izquierdo Puente JC; Barahona BE
Ginecol Obstet Mex; 2002 Aug; 70():379-84. PubMed ID: 12448041
[No Abstract] [Full Text] [Related]
50. Identification of placental cytokine-producing cells in term and preterm labor.
Steinborn A; von Gall C; Hildenbrand R; Stutte HJ; Kaufmann M
Obstet Gynecol; 1998 Mar; 91(3):329-35. PubMed ID: 9491855
[TBL] [Abstract][Full Text] [Related]
51. Cervical fetal fibronectin in patients at increased risk for preterm delivery.
Bittar RE; Yamasaki AA; Sasaki S; Zugaib M
Am J Obstet Gynecol; 1996 Jul; 175(1):178-81. PubMed ID: 8694047
[TBL] [Abstract][Full Text] [Related]
52. Interleukin 6 and fetal fibronectin as a predictors of preterm delivery in symptomatic patients.
Hadzi Lega M; Daneva Markova A; Stefanovic M; Tanturovski M
Bosn J Basic Med Sci; 2015 Jan; 15(1):51-6. PubMed ID: 25725144
[TBL] [Abstract][Full Text] [Related]
53. Interleukin-1alpha, interleukin-6 and interleukin-8 in cervico/vaginal secretion for screening of preterm birth in twin gestation.
Wennerholm UB; Holm B; Mattsby-Baltzer I; Nielsen T; Platz-Christensen JJ; Sundell G; Hagberg H
Acta Obstet Gynecol Scand; 1998 May; 77(5):508-14. PubMed ID: 9654172
[TBL] [Abstract][Full Text] [Related]
54. Assessment of the impact of introducing fetal fibronectin assay in the management of preterm labour at Middlemore Hospital, New Zealand.
Musaad SM; Melson CL; Boswell DR
Pathology; 2005 Jun; 37(3):226-30. PubMed ID: 16175896
[TBL] [Abstract][Full Text] [Related]
55. Beta-human chorionic gonadotropin and prolactin assays in cervicovaginal secretions as a predictor of preterm delivery.
Guvenal T; Kantas E; Erselcan T; Culhaoglu Y; Cetin A
Int J Gynaecol Obstet; 2001 Dec; 75(3):229-34. PubMed ID: 11728482
[TBL] [Abstract][Full Text] [Related]
56. Predicting preterm birth within 2 weeks in asymptomatic women with a short cervix: Combined effects of cervicovaginal fluid cytokine levels and fetal fibronectin test.
Ohori Y; Imai K; Tano S; Owaki T; Miki R; Nozaki Y; Ushida T; Kajiyama H; Kotani T
J Obstet Gynaecol Res; 2024 Apr; 50(4):587-595. PubMed ID: 38217336
[TBL] [Abstract][Full Text] [Related]
57. Sonographic measurement of cervical length and fetal fibronectin testing in threatened preterm labor.
Tsoi E; Akmal S; Geerts L; Jeffery B; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Apr; 27(4):368-72. PubMed ID: 16526097
[TBL] [Abstract][Full Text] [Related]
58. Cervicovaginal matrix metalloproteinase-9 and cervical ripening in human term parturition.
Choi SJ; Jung KL; Oh SY; Kim JH; Roh CR
Eur J Obstet Gynecol Reprod Biol; 2009 Jan; 142(1):43-7. PubMed ID: 19019525
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-6 concentrations in cervical secretions identify microbial invasion of the amniotic cavity in patients with preterm labor and intact membranes.
Rizzo G; Capponi A; Rinaldo D; Tedeschi D; Arduini D; Romanini C
Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):812-7. PubMed ID: 8885727
[TBL] [Abstract][Full Text] [Related]
60. Correlation of cervical length, fetal fibronectin, phIGFBP-1, and cytokines in spontaneous preterm birth up to 14 days from sampling.
Hadži-Lega M; Markova AD; Stefanovic M; Tanturovski M
J Perinat Med; 2015 Sep; 43(5):545-51. PubMed ID: 25503663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
